Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; A national prospective cohort study in Norway from 2015 to 2017

dc.contributor.author	Vold, Jørn Henrik
dc.contributor.author	Aas, Christer Frode
dc.contributor.author	Skurtveit, Svetlana
dc.contributor.author	Odsbu, Ingvild
dc.contributor.author	Chalabianloo, Fatemeh
dc.contributor.author	Halmøy, Anne
dc.contributor.author	Johansson, Kjell Arne
dc.contributor.author	Fadnes, Lars T.
dc.date.accessioned	2023-05-08T10:41:20Z
dc.date.available	2023-05-08T10:41:20Z
dc.date.created	2020-09-20T12:59:18Z
dc.date.issued	2020
dc.identifier.citation	BMC Psychiatry. 2020, 20:119 1-12.
dc.identifier.issn	1471-244X
dc.identifier.uri	https://hdl.handle.net/11250/3066985
dc.language.iso	eng
dc.title	Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; A national prospective cohort study in Norway from 2015 to 2017
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.pagenumber	1-12
dc.source.volume	20:119
dc.source.journal	BMC Psychiatry
dc.identifier.doi	10.1186/s12888-020-02526-y
dc.identifier.cristin	1831395
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1